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Editorial Comment 
Creatine Kinase Re~ease After 
Brief Coronary Occlusion* 
MICHAEL C. FISHBEIN, MD, FACC 
Los Angeles, California 
The clinical appllcation of cardiac enzymology is based on 
the generally held opinion that increased levels of myo•
cardial enzymes in the peripheral blood indicate that myo•
cardial cell death has occurred, The implications of this 
n~tion are that 1) certain enzymes are present only ip the 
myocardium, and 2) they are not released with reversible 
forms of myocardial injury. Both of these concepts \lave 
been challenged in clinical and experimental studies. 
Creatine kinase-ME (CK-MB) has been demonstrated ip 
organs other than the heart (1); small amounts are present 
in the gastrointestinal tract, urinary system, liver, central 
nervous system and, rarely, in neoplasms (2). In patients 
with cardiomyopathy and in marathon n.mners, substantial 
amounts of CK-MB have been demonstrated in skeletal 
m~scle (3). In acute ischemic syndromes, t\lese sources of 
enzyme usually do not limit the utility of S~Illm measure•
ments of CK-MB. However, if CK-MB is released fro~ 
ischemic but noninfarcted myocardium, extensive reeval•
uation of current diagnostic and therap~utic strat~gies would 
be necessary. Most experimental studies in intact animals, 
isolated hearts and individual cells in culture, using a num•
ber of models of ischemia and a variety of techniques for 
detecting necrosis, have shown that cell death (Qecrosis or 
irreversible injury) is required for detectable enzyme leakage 
from myocardial cells. Other studies in comparable systems 
and using similar techniques, however, have been reported 
to demonstrate enzyme leakage from myocardial cells in the 
absence of cell death. Thus, it was concluded from these 
latter studies that reversible myocardial injury that does not 
cause cell death can resllit ip alterations of cell membrane . . . 
permeability with release of myocardial enzymes. 
Th~ study by Heyndrickx et al. (4) in this issue of the 
JOllmal provides additional data supporting the minority 
opinion. T~e al!t~ors fpund that in six instrumented baboons 
with 15 minutes of closed chest left anterior descending 
coron;py' arte~y oc~lusion foliowed by 24 hours of retlow 
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there was substantial release of CK and CK-MB into the 
peripheral blood in the absence of myocardial necrosis at 
autopsy. They concluded that the CK must have been re•
leased from the ischemic, but not the necrotic, myocardium. 
Meth9dologic con~iderations. How does one (like me) 
whose preconceived bias and observations (5,6) suggest that 
necrosis is necessary for CK release attempt to discount the 
findings of .fIeyndrick~ et al.? It is difficult. In the first 
place, it is unlikely that the substances being measured in 
the blood were not CK apd CK-MB. Seco!,!d, in a reper•
fusion model, with aniJIlals killed 24 hours after coronary 
occlusion, it is not difficu~t to' detect myocardial necrosis, 
especially because gross histochemical staining (triphenyl•
tetrazolium chloride [TIC]) and histologic examination were 
both employed. Third, a noncardiac source of the elevated 
CK blood levels seems very unlikely because no such el•
evation was observed in control, instrumented animals that 
had no coronary occlusion. 
The staunch skeptic, however, might have preferred more 
methodologic details assuring exhaustive sampling of each 
heart, with special emphasis on possible "artifactuql" sources 
of CK release, such as the myocardium adjaCent to the 
occluded artery, which could have been traumatized by the 
hydraulic occluder or the artery itself which could have been 
the source of CK. In our laboratory, we have observed that 
vigorous clamping of a peripheral artery results in elevation 
of total CK in the blood distal to the site of mechanical 
trauma (unpublished observations). Furthermore, the au•
thors' findings would have been more conclusive if they 
had shown decreased CK levels in the ischemic myocar•
dium. Because CK levels were measured in the normal 
myocardium and the ischemic zones were identifiable by 
the microsphere studies, these data could have been ob•
tained. An additional control to exclude CK release related 
to the trauma of coronary occlusion, such as a few seconds 
of coronary occlusion followed by retlow, would also haye 
been desirable. 
Are there any other aspects of this study th~t merit ap•
ditional consideration before its conclusions are accepteq? 
Why in this reperfusion model was the time to peak CK 
release unusually long (9.3 hours) (7)? Why was there me•
tachronous peaking of total CK (9.3 hours) and CK-MB 
(4.5 hours), ,which is not typical in clinical myocardial in•
farction (8)? If, as the authors suggest, the findings can be 
explained by gradual, prolonged membrane qamage leading 
to increased p~rweability, then why wouldn't other enzymes 
leak out, &uch as the diaphorases, dehydrogenases and re•
duced coeqzymes that are responsible for normal TTC stain•
ing of myocardium (9)? 
Clinical implit:ations. Admittedly, many of these com•
ments ~ight seem insignificant, were this not a subject of 
such clinical irpportance. In patients with acute ischemic 
syndromes, can elevated blood levels of CK anq CK-MB 
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no longer be regarded as diagnostic of myocardial infarc•
tion? Did patients who had percutaneous transluminal coro•
nary angioplasty and subsequently demonstrated elevated 
blood CK levels have myocardial necrosis, transient myo•
cardial ischemia or simply coronary artery trauma? Can CK 
peaks and curves be used to estimat~ infarct size if CK 
release occurs in the absence of necrosis?' 
To prove that ischemia can result in elevated levels of 
CK-MB in the peripheral blood, the source of the CK-MB 
must be identified as the ischemic myocardium, All other 
sources such as traumatized myocardium or coronary artery 
must be excluded, The findings of Heyndrickx et al. remind 
us of several well known facts: I) There is no perfect lab•
oratory test; 2) biologic systems are rarely as straightforward 
as we would like to believe; and 3) more studies are always 
needed, 
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